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Abstract
Background
In Nigeria, recent reports suggest that dengue viruses could be a major cause of acute
fevers. We sought to make a cross-sectional estimate of the prevalence of current and previ-
ous dengue infections in patients presenting with fever to healthcare centres in Cross River
State Nigeria.
Methodology/Principal findings
This cross-sectional health facility survey recruited persons with temperature�38˚C. Den-
gue virus immunoglobulin M (IgM)/immunoglobulin G (IgG) antibody testing using Onsite
Duo dengue Ag-IgG/IgM lateral flow immunoassay cassettes was done. Samples which
tested positive were further confirmed using the RecombiLISA dengue IgM and IgG enzyme
linked immunosorbent assay kits and classified into primary and secondary dengue infec-
tion. Malaria testing was carried out using microscopy. Between 4 January 2017 and 24
August 2017 a total of 420 participants were sampled across 11 health centres. The mean
age was 34 (range = 1–99), 63% were female, 49% reported sleeping under a treated mos-
quito net in the past week and 44% reported taking an antimalarial prior to seeking care. The
mean number of days fever was present prior to seeking care was 8, and many of the partic-
ipants presented with symptoms indicative of respiratory or urinary tract infections. Testing
indicated that 6% (95% CI: 2, 13; n = 24) had either a primary or secondary dengue infection
with or without co-existing malaria, while 4% (95% CI: 2, 9; n = 16) had either a primary or
secondary dengue infection without co-existing malaria. 52% (95% CI: 46, 58; n = 218) had
a malaria infection with or without any dengue infection, and 50% (95% CI: 44, 57; n = 210)
had a malaria infection without any dengue infection.
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Conclusion
Our study confirms the presence of dengue at not insignificant levels in patients attending
health centres with fever in this south eastern province of Nigeria. These data highlight the
danger of the common presumption in this setting that fever is due to malaria. Surveillance
for dengue is vital in this setting.
Introduction
Dengue is the most important arboviral infection of humans caused by four dengue virus sero-
types, namely dengue virus 1,2,3, and 4 (DENV 1–4), which belong to the Flaviviridae family
[1]. On a global scale, the sharp increase in prevalence of dengue recorded in recent decades
has caused it to be regarded as a major international public health concern. With an estimated
annual incidence of 390 million cases [2], dengue poses a risk to 2.5–3.6 billion people [3]
annually in over 125 endemic countries and has a case fatality rate exceeding 5% in some areas
[4]. The high morbidity and economic impact of dengue are well understood in many tropical
countries across Asia and Latin America [5,6]. However, across Africa the burden of dengue
remains very poorly documented, despite serologic evidence indicating DENV infections are
present in several countries [7,8]. In Nigeria recent reports suggest that DENV could be a
major cause of acute fevers [9], although many people presenting with fever to health facilities
get treated with an antimalarial without confirmatory tests despite the overlap in symptoms
between malaria and dengue. The dengue mosquito vectors (principally Aedes aegypti and Ae.
albopictus) are known to be well established [4], and serologic evidence indicates the presence
of DENV infections in some cities [1,10–13]. However, evidence on the prevalence of DENV
infections in Nigeria from more robust and generalisable surveys is lacking.
It is clearly important that the burden of dengue be accurately defined, ideally across rele-
vant spatial scales for public health planning. This is particularly important given that arboviral
surveillance programmes are not yet well established in Nigeria. We therefore sought to make
a cross-sectional estimate of the prevalence of current and previous DENV infections in
patients presenting with fever to health-care centres across Cross River State, Nigeria, and to
understand the risk factors associated with DENV infection.
Methods
Study setting
In Cross River State there are 576 primary health-care centres (PHCs) and 157 secondary
health-care centres, distributed across eighteen local government areas (LGAs), covering a
population of approximately 3,866,300 [14]. These PHCs and secondary health-care centres
are evenly divided across the three senatorial districts within the state which are Southern,
Central and Northern senatorial districts. PHCs are government owned, and LGAs are respon-
sible for managing them. They provide primary care for patients with typically acute condi-
tions, ante-natal services and immunization for children. PHCs are typically staffed by a range
of nurses, healthcare assistants and community health extension workers (usually 4–6 staff per
PHC). The secondary health-care centres are mostly government-owned and the others are
either privately-owned or run by missionary organizations. Cross River State has a tropical cli-
mate, with heavy rainfall during the wet season (April—November), and consists of the man-
grove, tropical rain forest in the south and central zones, with the savannah woodlands in the
Facility seroprevalence of dengue fever in Cross River, Nigeria
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north. It has a total land area of about 23,000 km2. The vectors of dengue–Aedes aegypti and
Aedes albopictus–have been identified in parts of Cross River from a previous entomological
survey [15].
Study design and sample size
This cross-sectional facility survey was conducted between January and August 2017 in health
facilities (mostly PHCs) across Cross River State. It was not possible to obtain a probability
sample because of the need to recruit patients presenting at facilities with fever. We therefore
used random sampling methods to first select a probability sample of health facilities, but then
had to take a non-probability sample of patients from those health centres. Specifically, in the
first stage of sampling 10 LGAs were selected with probability proportional to the number of
health centres across the three districts. In the second stage of sampling 1 health centre per
LGA was randomly selected. Field teams then visited the health centre, initially for 2–3 days,
and consecutively recruited patients into the study with the aim of reaching the sample size
per facility in all facilities. However, in a number of facilities recruitment was much slower
than anticipated. Therefore, in those facilities where recruitment was faster more patients were
recruited than the necessary number per facility to reach the overall sample size, and in facili-
ties where recruitment was very low another health centre from the same LGA was randomly
selected and patients sampled there as well.
Based on our resources we estimated that we could recruit a total of 396 participants (on
average 33 per health centre), which we calculated would allow us to estimate the prevalence of
DENV infections with a precision (i.e. 95% confidence interval) of at most ± 7.8%. This made
the conservative assumption that we would be estimating a prevalence of 50%, and that there
would be a design effect of 2.5, which was a conservative inflation of the design effect found in
the Nigeria 2015 Malaria Indicator Survey for the estimated prevalence of malaria in children
(aged 6–59 months) based on rapid diagnosis testing [16].
Study population
The study population was consenting febrile patients presenting to sampled health centres
who met the following eligibility criteria: age�1 year and fever (axillary temperature
of� 37.5˚C) for< 10 days.
Laboratory methods
Following strict aseptic technique and using sterile needles and 10 ml syringes, 6ml of blood
was withdrawn by venepuncture. Five mls of blood was delivered into a plain serum tube
while 1 ml was put in an EDTA bottle, both labelled with patient hospital and study numbers.
Thick blood smears were made on two grease-free slides and stained with 10% Giemsa for 10
minutes. The films were viewed using a compound light transmission microscope at a magnifi-
cation of X1000. In this study, positive slides were determined by the presence of merozoites
or ring forms of the malaria parasites. No schizonts or gametocytes were seen in this study.
Two hundred fields were viewed before a film was declared negative.
Blood samples were transported in a cold chain to the University of Calabar Teaching Hos-
pital (UCTH) for serum separation and storage. Serum was obtained from the plain bottle
sample by centrifugation at 5000 rpm for 10 minutes, and was used for the rapid detection of
DENV immunoglobulin M (IgM)/immunoglobulin G (IgG) antibody using Onsite Duo Den-
gue Ag-IgG/IgM lateral flow immunoassay cassettes (CTK Biotech Inc, San Diego, USA),
according to the manufacturer’s instructions. Samples which tested positive were further con-
firmed using the RecombiLISA Dengue IgM and IgG 96-well enzyme linked immunosorbent
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assay (ELISA) kits (CTK Biotech Inc, San Diego, USA), according to the manufacturer’s
instructions. Detection of IgM alone or an IgM:IgG optical density (OD) ratio�1.2 was desig-
nated as primary dengue, while the detection of IgG alone or an IgM:IgG OD ratio <1.2 was
designated as secondary dengue [17–19].
Data collection methods, instruments and quality assurance
Data was collected from eligible and consenting participants or their caregivers using a pro-
forma that captured the individual-level variables of interest including age, sex, occupation
and use of mosquito preventive measures (insecticide treated nets and indoor residual spray-
ing), home roof type, household location (urban/rural), household water storage and travel
history. The information obtained was then entered into a data management system, including
restrictions over the type and range of values allowed to reduce data entry errors. Quality
control checks were performed on 10% of entered records to reduce the occurrence of entry
errors. Also, 5% of the laboratory tests were repeated by an independent pathologist to corrob-
orate the laboratory results obtained.
Outcomes
The primary outcome was the prevalence of a primary or secondary dengue infection among
participants with or without malaria. The secondary outcomes were the prevalence of1) pri-
mary or secondary dengue without malaria, 2) primary dengue with malaria, 3) primary den-
gue without malaria, 4) secondary dengue with malaria, 5) secondary dengue without malaria,
6) malaria with/without primary/secondary dengue, 7) malaria with primary/secondary den-
gue, and malaria without primary/secondary dengue.
Statistical analysis
Data were analysed using R’s survey package [20–22] commands to allow results to account for
the clustering of the study design by health centre, via Taylor Series Linearisation methods
[22] for complex survey data analysis. Descriptive statistics (means, SDs and percentages) were
calculated to describe the characteristics of the sampled population in terms of their general
sociodemographic features and known risk factors for dengue (e.g. residence location, dwell-
ing characteristics etc). Percentage and frequency estimates for all outcomes were calculated
along with their 95% confidence intervals. Because all outcomes were binary their 95% confi-
dence intervals were calculated using the survey package svyciprop function’s logit method,
which “fits a logistic regression model and computes a Wald-type interval on the log-odds
scale, which is then transformed to the probability scale”. Multivariate logistic regression
was also used to evaluate the direction, magnitude and statistical significance of associations
between a range of risk/protective factors and dengue (primary or secondary) positivity (with
or without malaria co-infection), via adjusted odds ratios and their 95% confidence intervals,
with two-sided hypothesis testing conducted at the 5% level. All independent variables were
chosen before constructing the model based on evidence from the literature. Observations
with missing outcome and/or covariate data were omitted from the model. Given the small
size of the dataset this analysis should be treated as strictly exploratory.
Ethical considerations
Ethical clearance was duly obtained from the Health Research and Ethics Committee of the
UCTH with number UCTH/HREC/33/324. Written informed consent was obtained from
either the participants or their caregivers (in the case of minors) prior to the recruitment and
Facility seroprevalence of dengue fever in Cross River, Nigeria
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sample collection. Participation was voluntary and the cost of the tests were not be borne by
the participants.
Results
A total of 11 health centres were sampled, with an additional health centre selected in one
LGA due to a very low recruitment rate. Dates of patient recruitment varied across health cen-
tres. Across all health centres the earliest date of patient recruitment was 4 Jan 2017 and the lat-
est was 24 Aug 2017. Across all health centres the range in the number of days between first
and final patient recruitment dates was 0–232 (median = 97).There was also a large amount of
variation in the number of patients recruited per facility, with a median sample size of 34 and
a range of 2-96.There were a total of 420 participants with a mean age of 35 and 63% being
female(Table 1).Twenty-six percent (26%) had university education, while 17% had not
received any formal education. Fifty-nine (59%) resided in a rural area, with the mean house-
hold size being 5. Most (90%) participants lived in houses roofed with sheet metal. 46% had
waste around their homes, but 86% also indicated that they practiced some form of environ-
mental management to keep waste down to a minimum. Forty-nine (49%) reported sleeping
under a mosquito net during the previous week (Table 2). The use of mosquito nets on
doorways and windows was a common practice (65%). The use of antimalarials prior to pre-
sentation at a healthcare facility was also frequently reported (44%). The average axillary tem-
perature among participants was 38˚C, and the mean duration of fever was 8 days. Many of
the participants presented with symptoms indicative of urinary tract and respiratory infec-
tions, namely dysuria, cough/coryza, breathlessness and sore throats (Table 1).
6% (95% CI: 2%, 13%) of participants had antibody test results consistent with either a pri-
mary (first infection) or secondary dengue infection with or without malaria, and 4% (95% CI:
2%, 9%) were positive for primary/secondary dengue alone (i.e. without malaria). Fifty percent
(95% CI: 44%, 57%) of participants who had a positive malaria test were negative for both pri-
mary and secondary dengue, and 52% (95% CI: 46%, 58%) of the participants were positive for
both malaria and primary/secondary dengue (Table 3).
The logistic regression model showed that age, gender, educational level, place of residence,
presence of waste around house and the use of any household malaria protection were not
clearly associated with having either primary and/or secondary dengue (Table 4). Household
roof type was originally included in the model as a known risk factor for dengue, but due to
complete separation for some categories had to be removed.
Discussion
We found that 6% of patients tested positive for primary or secondary DENV infections either
with or without a malaria co-infection. In these undifferentiated fever cases 50% tested positive
for malaria but not dengue, while just 2% had co-existing primary dengue and malaria infec-
tions (and none had secondary dengue and malaria positivity).Symptoms indicative of urinary
tract and respiratory infections were commonplace among this cohort and may account for
some proportion of the fevers experienced. Dengue seroprevalence from a survey done in Mai-
duguri [11] Northern Nigeria was 10.1% (testing specifically for DEN V 3 using a microneutra-
lization assay) and was 17.2% in Ogbomoso [13], South Western Nigeria (testing for dengue
IgM using ELISA). However, these studies used a one-stage testing for dengue antibodies
using microneutralization and ELISA respectively. To the best of our knowledge, this is the
first survey of dengue seroprevalence from any setting in the South Eastern part of Nigeria.
Nigeria is a West African country in which dengue is reported to be endemic [11]. How-
ever, it is likely that many cases of dengue in Nigeria are often undiagnosed or misdiagnosed
Facility seroprevalence of dengue fever in Cross River, Nigeria
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as malaria or referred to as fever of unknown cause. Although there have been several
reported isolated outbreaks of dengue infection, still it is likely that many outbreaks have been
neglected, un recognized and under-reported due to unavailability of diagnostic tools and staff
unawareness in health institutions [12]. A clear method of identifying dengue infection from
among other acute undifferentiated tropical febrile illnesses is vital to facilitate appropriate tri-
age of patients and better clinical management of dengue cases. Serologic tests for dengue are
relatively inexpensive, quick and easy to perform and are available as point-of-care tests which
detect dengue NS1 antigen and anti-dengue IgM/IgG antigens. Because healthcare facilities
in many dengue endemic countries lack laboratory support, such simple diagnostic tests are
desirable. We used a lateral-flow diagnostic assay which cost less than $2 per test and could be
Table 1. Study population characteristics.
Total N 420
Age 35 (±19)
Sex F 63% (263)
M 37%(157)
Educational level None 17% (72)
Primary 28% (115)
Secondary 29% (122)
Tertiary 26% (109)
NA 0% (2)
Axillary temperature �38.1 (±0.72)
Days fever present prior to arrival 8(±12)
Other family members with fever No 58%(243)
Yes 42%(176)
NA 0%(1)
Cough/cold No 51%(215)
Yes 49%(205)
Difficulty in breathing No 76%(318)
Yes 24%(101)
NA 0%(1)
Dysuria No 77%(324)
Yes 23%(95)
NA 0%(1)
Sore ear No 89%(372%)
Yes 11%(44)
NA 1%(4)
Sore throat No 80%(335)
Yes 20%(84)
NA 0%(1)
Rash No 84%(351)
Yes 16%(67)
NA 0%(2)
Tender lymphadenopathy No 89%(372)
Yes 11%(46)
NA 0%(2)
Data are n, mean (SD) or %(n). For categorical variables missing data frequencies are provided but all other category
frequencies are calculated excluding missing data
https://doi.org/10.1371/journal.pone.0215143.t001
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Table 2. Details of housing conditions and protection against malaria.
Total N 420
Household location Urban 41%(171)
Rural 59%(249)
Household size 5(±3)
Number of bedrooms 3(±3)
Home roof type Sheet metal 90%(377)
Grass thatched 5%(20)
Tiles 4%(17)
Other 1%(3)
NA 1%(3)
Presences of waste No 54%(224)
Yes 46%(189)
NA 2%(7)
Presence of water storage No 24%(102)
Yes 76%(317)
NA 0%(1)
Environmental management No 14%(59)
Yes 86%(357)
NA 1%(4)
Slept under treated net in the previous week No 51%(211)
Yes 49%(204)
NA 1%(5)
Use mosquito net screen No 35%(147)
Yes 65%(273)
Use indoor spray coil No 58%(241)
Yes 42%(173)
NA 1%(6)
Apply insect repellent No 95%(396)
Yes 5%(22)
NA 0%(2)
Taken anti-malarial medication during present illness No 56%(223)
Yes 44%(178%)
NA 5%(19)
Data are n, mean (SD) or %(n). For categorical variables missing data frequencies are provided but all other category
frequencies are calculated excluding missing data
https://doi.org/10.1371/journal.pone.0215143.t002
Table 3. Dengue and malaria test outcomes.
Test diagnosis n (N = 420) % (95% CI)
Primary/secondary dengue with/without malaria 24 6% (2%, 13%)
Primary/secondary dengue without malaria 16 4% (2%, 9%)
Primary dengue with malaria 7 2% (1%, 5%)
Primary dengue without malaria 8 2% (1%, 6%)
Secondary dengue with malaria 1 0% (0%, 2%)
Secondary dengue without malaria 8 2% (1%, 5%)
Malaria with/without primary/secondary dengue 218 52% (46%, 58%)
Malaria with primary/secondary dengue 8 2% (1%, 6%)
Malaria without primary/secondary dengue 210 50% (44%, 57%)
https://doi.org/10.1371/journal.pone.0215143.t003
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done by laboratory technicians at primary care level. This point-of-care lateral flow assay for
dengue has been validated for use in dengue endemic areas [23,24] as it fulfils the World
Health Organization (WHO) Affordable, Sensitive, Specific, User-friendly, Rapid & Robust,
Equipment-free, and Delivered (ASSURED) criteria for point-of-care testing [25].
Dengue IgM levels begin to rise by the third day of a primary infection and peak at 2 weeks
after the onset of fever and may remain detectable for up to 6 months or longer following dis-
ease resolution. IgG is detectable at the end of the first week of illness and can persist for life.
ELISA tests can assay for IgM and IgG levels and the IgM: IgG ratio is useful in distinguishing
primary from secondary dengue virus infections. An IgM: IgG ratio of� 1.2 is indicative of
primary dengue infection while an IgM: IgG ratios of< 1.2 is indicative of secondary dengue
infection [18].
The diagnosis of dengue is further complicated by malaria co-infection as demonstrated in
our study. A recent survey done in the inland western Nigerian city of Ibadan put the number
of persons with active dengue infection among confirmed malaria cases at 10%. Among this
cohort of malaria cases, all of them were found to be positive for dengue IgG antibodies sug-
gestive of a past dengue infection and consistent with endemicity of dengue virus in this area
[26]. All these reflect a significant public health challenge that needs to be prioritised.
The use of mosquito nets has been recognised to be the most effective strategy for malaria
control [27], but the use of mosquito treated nets among this cohort did not meet the targets
set for malaria control in an endemic area. Effective use of the long-lasting insecticide treated
nets (LLIN) has been shown to significantly reduce the transmission of Aedes-borne diseases
such as dengue, Zika, yellow fever and chikungunya [28]. Interestingly, Aedes aegypti density
has been shown by the use of LLIN as window curtains [29]. Therefore, the LLIN appears to
hold much promise for the control of the diseases transmitted by these endophilic mosquitoes
and its widespread use should be promoted in the relevant climes. A significant proportion
(44%) of our participants took antimalarial treatment without malaria testing as recommended
in malaria management guidelines [30]. Up to 70% of all febrile cases in Nigeria are believed
to be misdiagnosed and presumptively treated as malaria. The erroneous belief that malaria
accounts for virtually all cases of fever in Nigeria is widespread among the populace. It is com-
monplace for persons with fever in Nigeria to self-medicate with two or three antimalarial
drugs before presenting to a health facility [31]. This is consistent with the findings here. Fol-
lowing improvements in malaria control efforts in low-middle income country (LMIC)
Table 4. Associations between dengue diagnosis (primary/secondary) and patient characteristics.
Outcome % (95% CI); p-valuea
Age 1 (1–1); 0.35
Male (ref = female) 0.6 (0.2–1.8); 0.39
Secondary/higher education (ref = none/primary) 1 (0.6–1.7); 0.97
Rural household (ref = urban) 1.1 (0.4–1.7); 0.84
Waste present at household (ref = no) 0.5 (0.2–1.4); 0.29
Water storage present at household (ref = no) 0.9 (0.3–2.6); 0.89
Any household mosquito protection usedb (ref = no household mosquito protection used) 0.6 (0.3–1.5); 0.38
9 (2.1%) observations were omitted due to missing covariate data.
aCoefficients were obtained from a logistic regression with the outcome of having a dengue (primary/secondary)
diagnosis vs having no dengue diagnosis, and were converted to odds ratios via exponentiation.
bAny mosquito household protection used included either a mosquito net screen, and/or a treated bed net and/or an
indoor spray coil.
https://doi.org/10.1371/journal.pone.0215143.t004
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contexts, it is believed that bacterial and viral pathogens account for the majority of cases of
acute febrile illnesses [32,33]. However, there appears to be limited baseline understanding of
these pathogens with a disproportionate focus on malaria leading to misdiagnosis and unwar-
ranted treatment. This may result in a misapplication of scarce resources and inadvertently
drive resistance to the currently available antimalarials. Indeed the preoccupation with malaria
in the LMICs may be constituting a barrier to understanding the complex communicable dis-
eases epidemiology that characterise these countries.
Rapid population growth, unplanned urbanization, increased international travel, agricul-
tural development, possible global climate changes are some of the factors that have been put
forward to explain the extensive transmission of dengue in these areas [34]. Other enabling
factors include ineffective mosquito control measures and the limited allocation of resources
to public health infrastructure [35]. However, none of the variables in our logistic regression
model (namely age, sex, education, place of residence, presence of waste around house, pres-
ence of water storage at house, and the use of any household malaria prevention strategies)
were associated with dengue infection status. It is not clear why no associations were found,
but limited sample size and therefore power may be a major reason.
Clearly there is need it for algorithmic guidelines, including universal malaria and selective
dengue testing, for the diagnosis and management of patients with fever presenting to primary
and secondary care in Nigeria. This pragmatic framework for triage and testing of undifferen-
tiated cases of fever in resource limited settings is critical in determining the clinical outcomes
of patients with dengue. These guidelines will need to reflect the fact that about half of these
undifferentiated cases are neither due to malaria nor dengue, but may rather be related to
respiratory or urinary infections. Such guidelines will need to include methods of identifying
dengue related complications to promote optimum management and referral of relevant cases.
Our study confirms the presence of DENV infections in patients attending PHCs in this
south eastern province of Nigeria. Surveillance for dengue is vital in this setting for identifying
outbreaks and initiating an early response.
This study has several limitations. First, our survey did not use a probability sampling
method, given that although we took a probability sample of health facilities we had to take a
non-probability sample of patients from within those facilities. This therefore prevented the
calculation of weights and limits the robustness and generalisability of the estimates, given that
inferential statistics formally assume the data come from a random probability sample. Second,
this is a facility-based survey, and so we cannot generalize our results to the community or
wider population outside of those attending health facilities for fever, which would require a
population survey. Third, dengue shows seasonal trends, and the data were collected over a
large proportion of the year and importantly with uneven effort across that time period.
Hence, the overall percent prevalence estimates do not represent the prevalence from any sin-
gle part of the year, nor do they represent an evenly sampled average across the whole year.
The results should therefore be treated cautiously as likely indicative of the broad level of den-
gue infections in patients attending PHCs with fever. Fourth, we were unable to definitively
determine the proportion of patients with other febrile conditions.
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